EUVIMEDEUVIMED entdecken
Crossref

Genomic Profiling Reveals Immune-Related Gene Differences in Lung Cancer Patients Stratified by PD1/PDL1 Expression: Implications for Immunotherapy Efficacy

Zhifeng Ye, Ting Huang, Keke Hu, HeRan Zhou, Ling Huang, Lu Wang

Journal of Applied Genetics · 2025

DOI: 10.1007/s13353-024-00841-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Genetics, 2025. Verfasst von Zhifeng Ye und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hangzhou TCM Hospital of Zhejiang Chinese Medical University (Hangzhou Hospital of Traditional Chinese Medicine), Zhejiang, Hangzhou, China. Hauptthemen laut MEDLINE: Lung Neoplasms, B7-H1 Antigen, Programmed Cell Death 1 Receptor, Immunotherapy. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer remains a leading cause of global cancer-related mortality, and the exploration of innovative therapeutic approaches, such as PD1/PDL1 immunotherapy, is critical. This study leverages comprehensive data from the Cancer Genome Atlas (TCGA) to investigate the differential expression of PD1/PDL1 in lung cancer patients and explores its implications. Clinical data, RNA expression, somatic mutations, and copy number variations of 1017 lung cancer patients were obtained from TCGA. Patients were categorized into high (HE) and low (LE) PD1/PDL1 expression groups based on mRNA levels. Analyses included differential gene expression, functional enrichment, protein-protein interaction networks, and mutational landscape exploration. The study identified 391 differentially expressed genes, with CD4 and PTPRC among the upregulated genes in the HE group. Although overall survival did not significantly differ between HE and LE groups, enrichment analysis revealed a strong association with immunoregulatory signaling pathways, emphasizing the relevance of PD1/PDL1 in immune response modulation. Notably, TP53 mutations were significantly correlated with high PD1/PDL1 expression. This study provides a comprehensive analysis of PD1/PDL1 expression in lung cancer, uncovering potential biomarkers and highlighting the intricate interplay between PD1/PDL1 and the immune response. The identified upregulated genes, including CD4 and PTPRC, warrant further investigation for their roles in the context of lung cancer and immunotherapy. The study underscores the importance of considering molecular heterogeneity in shaping personalized treatment strategies for lung cancer patients. Limitations, such as the retrospective nature of TCGA data, should be acknowledged.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsB7-H1 AntigenProgrammed Cell Death 1 ReceptorImmunotherapyHumansGene Expression Regulation, NeoplasticBiomarkers, TumorMutationMaleFemaleGene Expression ProfilingDNA Copy Number VariationsMiddle Aged

Stichwörter der Autor:innen

ImmunotherapyLung cancerPD1PDL1

Substanzen

B7-H1 AntigenProgrammed Cell Death 1 ReceptorCD274 protein, humanPDCD1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Hangzhou TCM Hospital of Zhejiang Chinese Medical University (Hangzhou Hospital of Traditional Chinese Medicine), Zhejiang, Hangzhou, China.
  • Hangzhou TCM Hospital of Zhejiang Chinese Medical University (Hangzhou Hospital of Traditional Chinese Medicine), Zhejiang, Hangzhou, China. yzf2012@163.com.

Zitieren

APA

Ye, Z., Huang, T., Hu, K., Zhou, H., Huang, L., & Wang, L. (2025). Genomic Profiling Reveals Immune-Related Gene Differences in Lung Cancer Patients Stratified by PD1/PDL1 Expression: Implications for Immunotherapy Efficacy. Journal of Applied Genetics. https://doi.org/10.1007/s13353-024-00841-8

Vancouver

Ye Z, Huang T, Hu K, Zhou H, Huang L, Wang L. Genomic Profiling Reveals Immune-Related Gene Differences in Lung Cancer Patients Stratified by PD1/PDL1 Expression: Implications for Immunotherapy Efficacy. Journal of Applied Genetics. 2025. doi:10.1007/s13353-024-00841-8

BibTeX
@article{Ye2025,
  author = {Ye, Zhifeng and Huang, Ting and Hu, Keke and Zhou, HeRan and Huang, Ling and Wang, Lu},
  title = {Genomic Profiling Reveals Immune-Related Gene Differences in Lung Cancer Patients Stratified by PD1/PDL1 Expression: Implications for Immunotherapy Efficacy},
  journal = {Journal of Applied Genetics},
  year = {2025},
  doi = {10.1007/s13353-024-00841-8}
}
Kostenlos starten →